#Peripheral Vascular Devices Market

[poonamcmi]

Peripheral Vascular Devices Market is Estimated to Witness High Growth Owing to Rising Geriatric Population

Peripheral vascular devices are used for the treatment and diagnosis of peripheral artery diseases. These devices help in plaque removal, angioplasty and stenting which restore smooth blood flow to limbs. The rising prevalence of peripheral artery diseases due to diabetes, obesity and high blood pressure has fueled the demand for peripheral vascular devices. Peripheral vascular devices include angioplasty balloons, stents, catheters, arterial sheaths, guidewires and other devices. Technologically advanced devices with enhanced safety, efficacy and ease of installation have gained traction in the recent years.

The global peripheral vascular devices market is estimated to be valued at US$ 12.68 Bn in 2024 and is expected to exhibit a CAGR of 6.3% over the forecast period 2024 to 2031.

Key Takeaways Key players operating in the peripheral vascular devices are Abbott Laboratories, Boston Scientific Corporation, Angioscore, Emboline Inc., Becton Dickinson and Company, Cook Group Inc., Cordis Corporation, Covidien PLC, Edward Lifesciences Corporation, Medtronic Plc, St. Jude Medical, Bayer AG., Teleflex Medical, Koninklijke Philips N.V., Cardio Flow, Inc. Key players are focusing on new product launches, mergers and acquisitions to strengthen their market presence.

The rising geriatric population prone to peripheral artery diseases and growing preference for minimally invasive surgeries offer significant growth opportunities for players in the Peripheral Vascular Devices Market Size Furthermore, expanding healthcare infrastructure and increasing healthcare expenditure in emerging economies is also expected to fuel the adoption of peripheral vascular devices globally over the forecast period.

Market Drivers The rising geriatric population is one of the key drivers of the peripheral vascular devices market. According to the UN data, the world’s population aged 60 years and above is projected to double from 12% to 22% between 2015 and 2050. The elderly are more susceptible to developing peripheral artery diseases owing to reduced blood circulation and weakening of arteries with age. This is expected to significantly drive the demand for peripheral vascular devices over the next few years.

PEST Analysis

Political: Peripheral Vascular Devices Market Size And Trends are subject to extensive government regulations resulting from stringent FDA approvals for new products and procedures. Regulations impact product development timelines and costs.

Economic: Growth in the peripheral vascular devices market is driven by rising healthcare expenditure, growing elderly population suffering from peripheral vascular diseases, and favorable reimbursement policies for life-saving procedures.

Social: Increasing awareness about peripheral vascular diseases and availability of advanced treatment options encourage people to seek medical care. Sedentary lifestyles and obesity rates also contribute to the patient volumes.

Technological: Innovation leads to the development of novel drug-eluting, bioresorbable, and nano-technology based stents that reduce in-stent re-stenosis rates. Robotics, AI, and 3D printing are enhancing surgical precision and customization.

Market value concentration by geographical regions: North America accounts for the largest share of the overall peripheral vascular devices market in terms of value, owing to the high usage of advanced equipment, growing number of vascular surgeries, and supportive insurance system. Asia Pacific is expected to witness the fastest value growth over the forecast period, with expanding healthcare infrastructure and increasing medical tourism from other regions.

Fastest growing regional market: Asia Pacific peripheral vascular devices market exhibits immense growth potential attributed to the rising awareness, healthcare reforms, and willingness to adopt modern treatments. Factors like growing elderly population, increasing obesity prevalence, presence of contract manufacturers and emerging economies propel the regional market growth at a rapid rate. Get More Insights On, Peripheral Vascular Devices Market About Author: Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)

[mitalipingale]

https://community.wongcw.com/blogs/786214/Peripheral-Vascular-Devices-Market-Size-Overview-Share-and-Forecast-2031

The Peripheral Vascular Devices Market in 2023 is US$ 11.47 billion, and is expected to reach US$ 17.63 billion by 2031 at a CAGR of 5.50%.

[healthchat]

Varicose Veins Treatment in Karimnagar

At Karimnagar, we understand that every patient is unique, which is why we take a personalized approach to each individual's care plan. We offer a comprehensive range of services, including routine foot care, wound care, vascular ultrasounds, and more, to help diagnose and treat a variety of conditions. Our state-of-the-art facility is equipped with the latest technology and equipment to ensure that you receive the best possible care.

Glue Treatment For Varicose Veins in Karimnagar Glue Treatment For Varicose Veins: Glue treatment, also known as VenaSeal, is a minimally invasive treatment for varicose veins. It involves the use of a medical adhesive, which is injected into the affected vein. The glue seals the vein, and blood is rerouted to healthier veins. The procedure is painless and requires no anesthesia.

Laser Treatment For Varicose Veins in Karimnagar Laser Treatment For Varicose Veins:Laser treatment is another minimally invasive procedure used to treat varicose veins. It involves the use of a laser to heat and seal the affected vein, causing it to collapse and eventually fade away. The procedure is performed under local anesthesia, and most patients can return to normal activities within a day.

Microsclerotherapy Treatment in Karimnagar Microsclerotherapy for Cosmetic Purpose:Microsclerotherapy is a cosmetic treatment used to remove spider veins or small varicose veins. It involves the injection of a sclerosing agent directly into the affected vein, causing it to collapse and fade away. The procedure is minimally invasive and requires no anesthesia.

Peripheral Artery Bypass Treatment in Karimnagar Peripheral Artery Bypass/Angioplasty/Stenting:Peripheral artery bypass, angioplasty, and stenting are procedures used to treat peripheral artery disease. They involve the use of a catheter to insert a balloon or stent into the blocked artery, allowing blood flow to be restored. The procedure is performed under local anesthesia and requires a short hospital stay.

Aortic Aneurysm center in Karimnagar Aortic Aneurysm Stenting/Open Surgery:Aortic aneurysm stenting and open surgery are procedures used to treat an aneurysm in the aorta. Stenting involves the insertion of a stent into the weakened section of the artery to support and reinforce it. Open surgery involves the surgical repair or replacement of the damaged portion of the artery. The procedure requires general anesthesia and a hospital stay.

Diabetic Foot Treatment in Karimnagar Diabetic Foot / Podiatric Surgery:Diabetic foot and podiatric surgery are procedures used to treat foot problems related to diabetes. They involve the removal of damaged tissue, the correction of deformities, and the treatment of infections. The procedures may be performed under local or general anesthesia, depending on the complexity of the surgery.

Day Care Surgeries in Karimnagar Day Care Surgeries:Day care surgeries are minor procedures that can be performed in an outpatient setting. They include procedures such as skin biopsies, mole removal, and minor laceration repairs. The procedures are performed under local anesthesia and patients can return home the same day.

Varicose vein treatment in Karimnagar Varicose vein treatment by Endovenous Ablation: Our clinic offers a minimally invasive treatment option for varicose veins known as endovenous ablation. This treatment is performed using a laser or radiofrequency energy to heat and close the affected veins, allowing blood to reroute through healthier veins. The procedure is quick, effective, and virtually painless with no scarring, allowing patients to return to their daily activities almost immediately.

Diabetic foot ulcers and Non-healing ulcer Management in Karimnagar Diabetic foot ulcers and Non-healing ulcer Management: Our clinic specializes in the management of diabetic foot ulcers and non-healing ulcers. Our expert team of vascular surgeons offers comprehensive treatment options to promote wound healing and prevent further complications. We use a multidisciplinary approach, including wound care, offloading, infection control, and vascular interventions to help patients recover quickly.

Peripheral bypasses, DVT management in Karimnagar Peripheral bypasses, DVT management: We offer advanced treatment options for peripheral arterial disease and deep vein thrombosis. Peripheral bypass surgery involves redirecting blood flow around a blocked artery using a graft, and we provide expert care for this procedure. Our team also offers specialized care for deep vein thrombosis, including anticoagulation therapy, compression stockings, and thrombectomy if necessary.

Aortic Aneurysm Treatment in Karimnagar Aortic Aneurysm Endovascular repair: Our clinic provides endovascular repair for aortic aneurysms, a less invasive alternative to traditional open surgery. The procedure involves inserting a stent-graft through a small incision, allowing us to repair the aneurysm without major surgery. This procedure offers faster recovery times, less pain, and fewer complications than traditional open surgery.

for more info:

[drsumitblog]

The Hidden Dangers of Peripheral Arterial Disease

Peripheral Arterial Disease (PAD) often lurks unnoticed, overshadowed by more commonly discussed health issues. Yet, its impact on the circulatory system and overall health is profound. Dr. Sumit Kapadia, a renowned name in vascular health, delves into the hidden dangers and lesser-known symptoms of this disease.

Understanding PAD

PAD is a condition marked by the narrowing of arteries in the legs due to atherosclerosis. This plaque buildup hampers blood flow, leading to a range of symptoms. While leg pain during physical activities is a known symptom, PAD also manifests in subtler signs like temperature changes in the legs, skin colour changes, slower growth of toenails, and even erectile dysfunction in men, especially those with diabetes.

The Importance of Early Detection

With advancements in medical science, including new treatments for PAD in 2023, recognizing these symptoms early has become crucial. Dr. Kapadia utilizes several diagnostic tests such as the Ankle-Brachial Index (ABI) and Doppler Ultrasound Imaging, which are instrumental in detecting PAD early and preventing its progression.

Conclusion

Understanding and recognizing the lesser-known symptoms of PAD are vital for early intervention. With advanced peripheral artery disease treatment and angioplasty options available, effectively managing PAD under the guidance of experts like Dr. Kapadia is more achievable than ever.

[neha24blog]

Peripheral Vascular Devices Market Segmented On The Basis Of Type, Region And Forecast 2030: Grand View Research Inc.

San Francisco, 6 July 2023: The Report Peripheral Vascular Devices Market Size, Share & Trends Analysis Report By Type (Peripheral Stents, PTA Balloons, Catheters, Endovascular Aneurysm Repair Stent Grafts, Plaque Modification Devices), By Region, And Segment Forecasts, 2023 – 2030 The global peripheral vascular devices market size is expected to reach USD 11,574.4 million by 2030, to expand at…

[vaiswr]

Peripheral Vascular Devices Market Size Worth USD 7.86 Billion in 2030

The global peripheral vascular devices market size was USD 4.41 Billion in 2021 and is expected to register a revenue CAGR of 6.6% during the forecast period, according to the latest analysis by Emergen Research. Increasing prevalence of peripheral vascular and artery diseases, rising tendency of obesity, diabetes, alcohol, and smoking, and increasing government approvals of peripheral vascular devices are some of the key factors driving revenue growth of the peripheral vascular devices market.

[waghaditi]

Angioplasty Balloons Market Growth Driven by Technological Advancements and Cardiovascular Diseases

The angioplasty balloons market has witnessed substantial growth in recent years due to various market drivers that are shaping its future. These drivers include an increase in cardiovascular diseases, advancements in medical technology, and an expanding global healthcare sector. This article explores the key market drivers that contribute to the expansion of the angioplasty balloons market and how they impact the industry.

Rising Incidence of Cardiovascular Diseases (CVDs) The growing prevalence of cardiovascular diseases, such as coronary artery disease (CAD) and peripheral artery disease (PAD), is one of the primary drivers of the angioplasty balloons market. According to the World Health Organization (WHO), cardiovascular diseases remain the leading cause of death globally. As the population ages and lifestyle-related factors like poor diet, smoking, and lack of physical activity increase, the incidence of CVDs continues to rise. This trend drives the demand for angioplasty procedures, which are essential for treating blockages in the arteries and restoring blood flow.

Technological Advancements in Medical Devices Technological innovation has significantly contributed to the angioplasty balloons market. Newer generations of angioplasty balloons, such as drug-eluting balloons (DEBs), cutting balloons, and bioresorbable balloons, are revolutionizing the treatment of vascular diseases. These advancements not only improve the efficiency of angioplasty procedures but also reduce the risk of restenosis (re-narrowing of arteries). DEBs, for example, are coated with drugs that help prevent the reoccurrence of blockages, leading to better long-term patient outcomes. Additionally, developments in balloon materials and designs make these devices more durable and easier to use.

Preference for Minimally Invasive Procedures There is a growing preference for minimally invasive medical procedures over traditional open surgeries. Patients and healthcare providers are opting for angioplasty, which is a minimally invasive procedure, due to its numerous benefits such as shorter recovery time, reduced complications, and lower risk of infection. The demand for angioplasty balloons is directly linked to this shift in preference. As more patients seek less invasive treatments for cardiovascular diseases, the angioplasty balloons market continues to grow, especially in developed regions where healthcare standards are high.

Increase in Healthcare Spending and Access to Advanced Healthcare As healthcare spending rises globally, particularly in emerging economies, the accessibility of advanced medical technologies, including angioplasty balloons, is improving. Many countries are investing in healthcare infrastructure, improving the availability of modern medical treatments. These developments have made angioplasty procedures more accessible to a larger portion of the population, driving the demand for angioplasty balloons. Additionally, as healthcare systems in developing countries become more sophisticated, the adoption of angioplasty balloons is expected to rise significantly.

Aging Population The aging global population is another key driver for the angioplasty balloons market. As people age, they become more susceptible to cardiovascular diseases. The elderly population is more likely to suffer from blocked arteries and other cardiovascular issues that require angioplasty. With a growing proportion of elderly individuals in developed countries and the aging population in emerging markets, the demand for treatments like angioplasty is increasing. Consequently, the need for angioplasty balloons is expected to rise significantly in the coming years.

Government Initiatives and Policies Government initiatives aimed at improving cardiovascular health are also driving the angioplasty balloons market. Many countries are investing in preventive healthcare measures, conducting awareness campaigns, and increasing funding for cardiovascular research. Furthermore, government policies that promote healthcare accessibility and insurance coverage for angioplasty procedures help increase the adoption of angioplasty balloons. These initiatives ensure that more people receive timely treatments, thus expanding the market for angioplasty balloons.

Growing Awareness of Cardiovascular Health There has been a significant increase in public awareness of cardiovascular health, particularly due to the efforts of health organizations, governments, and non-governmental organizations. As individuals become more aware of the risks associated with poor cardiovascular health, they are more likely to seek preventive treatments and diagnostic procedures. This growing awareness has led to earlier diagnosis and treatment of cardiovascular diseases, boosting the demand for angioplasty procedures and, by extension, angioplasty balloons.

Increased Investment in Medical Research Investments in cardiovascular research are driving innovation in the angioplasty balloons market. Ongoing research is focused on improving the performance of angioplasty balloons and developing new types of devices with enhanced features. For example, efforts are being made to create drug-eluting balloons that release medications more effectively, reduce the risk of restenosis, and provide longer-lasting results. As medical research continues to advance, the angioplasty balloons market will likely experience further growth, with new products emerging that meet the needs of both patients and healthcare providers.

Improved Reimbursement Policies In many countries, particularly in North America and Europe, improved reimbursement policies have made angioplasty procedures more affordable and accessible. The availability of insurance coverage for angioplasty balloons has led to a rise in their usage, especially among patients who might have otherwise opted for less expensive treatments. Reimbursement policies that cover innovative treatments such as drug-eluting balloons and cutting balloons further support market growth.

Emerging Market Potential The angioplasty balloons market is also expanding in emerging economies, where increasing healthcare investments and a rising middle class are creating opportunities for growth. As healthcare systems in countries like India, China, Brazil, and Russia improve, more people in these regions are gaining access to advanced cardiovascular treatments. The demand for angioplasty balloons is set to increase significantly as more patients seek effective solutions for cardiovascular diseases.

[govindtbrc]

Peripheral Micro Catheters Market: Advances in Minimally Invasive Vascular Procedures up to 2033

Market Definition

The Peripheral Micro Catheters Market includes devices used in minimally invasive procedures for the diagnosis and treatment of various medical conditions. These micro catheters are smaller in diameter than traditional catheters, allowing for enhanced precision and access to peripheral vessels, which are difficult to reach with standard-sized catheters. They are used for a variety of applications, including angiography, angioplasty, embolization, and other interventional procedures in cardiology, neurology, and oncology.

To Know More @ https://www.globalinsightservices.com/reports/peripheral-micro-catheters-market

The Peripheral Micro Catheters Market is anticipated to expand from $1.2 billion in 2023 to $2.5 billion by 2033, with a CAGR of approximately 7.5%.

Market Outlook

The Peripheral Micro Catheters Market is experiencing significant growth, driven by the increasing demand for minimally invasive procedures in healthcare. The rising prevalence of chronic diseases such as cardiovascular disorders, cancer, and neurological conditions is contributing to the growing adoption of interventional techniques, thereby boosting the demand for peripheral micro catheters. These catheters enable healthcare providers to perform delicate procedures with greater accuracy, reduced trauma to patients, and faster recovery times, which is leading to their rising popularity in the medical field.

Technological advancements in catheter design are another major factor propelling market growth. Innovations aimed at improving the flexibility, steerability, and durability of peripheral micro catheters are allowing for better procedural outcomes. Furthermore, the development of next-generation micro catheters with enhanced features, such as advanced coatings to reduce friction, antimicrobial properties, and improved radiopacity, is attracting attention from healthcare providers, contributing to the market’s expansion.

The demand for peripheral micro catheters is also being driven by the growing trend toward outpatient and ambulatory procedures. With a preference for minimally invasive options, many patients are opting for procedures that require less recovery time and hospital stay, further increasing the adoption of peripheral micro catheters. Additionally, the increasing availability of diagnostic imaging systems such as ultrasound, MRI, and CT scans is improving the accuracy and efficiency of interventional procedures, which in turn supports the demand for precision devices like peripheral micro catheters.

Request the sample copy of report @ https://www.globalinsightservices.com/request-sample/GIS32135

[mitalipingale]

https://www.xaphyr.com/blogs/683982/Peripheral-Vascular-Devices-Market-Size-Overview-Share-and-Forecast-2031

The Peripheral Vascular Devices Market in 2023 is US$ 11.47 billion, and is expected to reach US$ 17.63 billion by 2031 at a CAGR of 5.50%.

[stephengrand]

North America Balloon Catheters Market Size, Share, Trends, Growth, Analysis, Forecast | 2024-2032

The North America balloon catheters market is poised for significant growth in the coming years, with the market size valued at USD 1.3 billion in 2023. It is expected to expand at a robust compound annual growth rate (CAGR) of 10.59% during the forecast period of 2024-2032, reaching an estimated value of USD 3.3 billion by 2032. This growth is largely driven by the increasing prevalence of cardiovascular diseases, the adoption of minimally invasive surgical procedures, and technological advancements in balloon catheter design.

Balloon catheters are medical devices that play a vital role in treating a range of cardiovascular conditions, such as coronary artery disease (CAD), peripheral artery disease (PAD), and other vascular disorders. The balloon catheter is inserted into a blood vessel, where it is inflated to widen narrowed or blocked arteries, thereby improving blood flow. This procedure, known as angioplasty, is commonly used to prevent heart attacks and strokes.

Get a Free Sample Report with Table of Contents : https://www.expertmarketresearch.com/reports/north-america-balloon-catheters-market/requestsample

This article delves into the key drivers, trends, challenges, market segmentation, and competitive landscape of the North American balloon catheters market. Additionally, it explores frequently asked questions (FAQs) about balloon catheters and highlights the key players shaping the market.

Market Drivers: Why Is the North America Balloon Catheters Market Expanding?

Several factors contribute to the expected growth of the balloon catheters market in North America:

1. Increasing Prevalence of Cardiovascular Diseases

The rise in cardiovascular diseases, including coronary artery disease, peripheral artery disease, and stroke, has been a major factor driving the demand for balloon catheter procedures. According to the American Heart Association, nearly 48% of the adult population in the U.S. has some form of cardiovascular disease. The growing number of patients requiring angioplasty or stenting has significantly boosted the adoption of balloon catheters.

2. Technological Advancements in Balloon Catheter Design

Innovation in balloon catheter design has improved their performance, safety, and ease of use, which has contributed to their increased adoption. Newer catheters are designed to have higher durability, smaller profiles, and better maneuverability, enabling surgeons to perform more complex procedures with greater precision. These advancements are expected to further fuel the growth of the market.

3. Shift Towards Minimally Invasive Procedures

Minimally invasive surgeries, including angioplasty, have become the preferred treatment option for many cardiovascular conditions due to their shorter recovery times, reduced risk of complications, and lower overall healthcare costs. Balloon catheter-based angioplasty procedures are less invasive than traditional surgery, which has increased their adoption across North America.

4. Aging Population

The ageing population in North America is another significant factor contributing to the growth of the balloon catheters market. As people age, the incidence of cardiovascular diseases increases, leading to a greater demand for interventional procedures like angioplasty, which often require balloon catheters.

5. Rising Healthcare Expenditure

Increased healthcare spending in North America, particularly in the U.S., has led to the adoption of advanced medical devices and treatments. The growing demand for high-quality healthcare services, along with the introduction of reimbursed medical procedures, is driving the use of balloon catheters for a range of cardiovascular treatments.

Market Challenges: Factors Limiting Growth

Despite the promising growth of the balloon catheters market, there are several challenges that could hinder its expansion:

1. High Cost of Balloon Catheters

One of the primary challenges facing the balloon catheter market is the high cost of advanced devices. While the technology behind balloon catheters continues to improve, the cost of these devices can be prohibitively high, especially for patients without insurance coverage or in regions with limited healthcare resources.

2. Risk of Complications During Procedure

While balloon catheter procedures are generally considered safe, there is still a risk of complications, such as arterial dissection, perforation, or restenosis (narrowing of the artery again after treatment). The occurrence of these complications can result in longer recovery times, additional treatments, or even the need for open surgery, which may deter some patients from opting for balloon angioplasty.

3. Regulatory Hurdles

The regulatory approval process for medical devices can be lengthy and costly. Manufacturers of balloon catheters must meet strict standards set by regulatory bodies, such as the U.S. Food and Drug Administration (FDA), which can delay the introduction of new products to the market.

Market Segmentation

The North American balloon catheters market can be segmented based on the following parameters:

1. Type of Balloon Catheters

Angioplasty Balloon Catheters: Used for coronary and peripheral artery procedures to widen narrowed or blocked arteries.

Cutting Balloon Catheters: These balloons have small blades that make incisions in the artery during inflation, enabling more effective dilation.

Scoring Balloon Catheters: These balloons have a scored surface that allows for better dilation of the arteries, particularly in cases of severe stenosis.

Drug-Eluting Balloon Catheters: These balloons are coated with drugs that help prevent restenosis after an angioplasty procedure.

2. Application Area

Coronary Artery Disease (CAD): Balloon catheters are extensively used in angioplasty for the treatment of CAD, one of the most common cardiovascular diseases in North America.

Peripheral Artery Disease (PAD): The growing incidence of PAD, particularly in older adults, has increased the demand for balloon catheters to treat narrowed arteries in the limbs.

3. End User

Hospitals: Hospitals are the primary end-users of balloon catheters, as they have the necessary infrastructure and skilled personnel to perform angioplasty procedures.

Cardiac Catheterization Laboratories (Cath Labs): Cath labs within hospitals are dedicated to performing procedures involving balloon catheters.

Ambulatory Surgical Centers (ASCs): These centers are seeing an increase in demand for minimally invasive procedures, including those involving balloon catheters.

Regional Analysis

North America holds the largest share of the balloon catheters market, with the U.S. leading the region in terms of market size and growth. The U.S. market is primarily driven by the high prevalence of cardiovascular diseases, the availability of advanced healthcare infrastructure, and the strong presence of leading balloon catheter manufacturers. Canada is also witnessing growth in the market, albeit at a slower pace due to its smaller population and healthcare system.

Competitive Landscape

The North America balloon catheters market is highly competitive, with several key players vying for market share. These companies are focusing on expanding their product portfolios, improving product quality, and entering into strategic partnerships to strengthen their market position. Some of the leading players in the market include:

1. Medtronic PLC

Medtronic is one of the dominant players in the balloon catheters market, with a wide range of angioplasty balloon catheters. The company has a strong presence in North America, with a broad distribution network and a well-established customer base.

2. Boston Scientific Corporation

Boston Scientific is another major player in the North American balloon catheter market. The company offers a wide range of balloon catheters for coronary and peripheral interventions, including drug-eluting balloon catheters.

3. Abbott Laboratories

Abbott is known for its innovative medical devices, including balloon catheters for cardiovascular interventions. The company has made significant strides in developing drug-eluting balloons for improved clinical outcomes.

4. Cook Medical

Cook Medical is a global leader in medical device innovation, providing a comprehensive range of balloon catheters for coronary and peripheral applications.

5. Terumo Corporation

Terumo is a Japanese medical device company with a strong presence in the North American balloon catheter market. The company’s offerings include cutting-edge balloon catheters for various vascular procedures.

6. Johnson & Johnson (Ethicon)

Ethicon, a subsidiary of Johnson & Johnson, is a leading player in the global balloon catheter market, providing high-quality devices for both coronary and peripheral artery procedures.

FAQs

1. What is a balloon catheter?

A balloon catheter is a medical device used in angioplasty procedures to widen narrowed or blocked arteries. It consists of a thin, flexible tube with a balloon at the tip that is inflated to compress plaque or blood clots in the arteries.

2. What are the types of balloon catheters?

The main types of balloon catheters are angioplasty balloon catheters, cutting balloon catheters, scoring balloon catheters, and drug-eluting balloon catheters.

3. What are the key applications of balloon catheters?

Balloon catheters are primarily used in the treatment of coronary artery disease (CAD) and peripheral artery disease (PAD), as well as for other vascular interventions.

4. What factors are driving the growth of the North America balloon catheters market?

The major drivers include the increasing prevalence of cardiovascular diseases, technological advancements in balloon catheter design, a shift towards minimally invasive surgeries, and an ageing population.

5. Who are the leading players in the North America balloon catheters market?

Key players include Medtronic PLC, Boston Scientific Corporation, Abbott Laboratories, Cook Medical, Terumo Corporation, and Johnson & Johnson (Ethicon).

[marketsndata]

Japan Wound Care Market Analysis 2031

Japan Wound Care Market size was valued at USD 1.61 billion in FY2023, and is expected to reach USD 2.39 billion in FY2031, with a CAGR of 5.1% for the forecast period between FY2024 and FY2031. The Japan wound care market is anticipated to grow, driven by factors such as the growing elderly demographic in Japan, a rising incidence of chronic diseases such as diabetes, and technological advancements. Given the elderly’s susceptibility to skin issues and their need for specialized wound care, the rise in demographics is a significant concern.

According to the Ministry of Internal Affairs and Communications’ population estimates, the number of individuals aged 65 and older increased by 60,000 in 2022, reaching a historical high of 36.27 million. An article published in the Journal of Nursing highlights how skin damage in the elderly, resulting from increased friction and shear forces, contributes to pressure ulcer development. Therefore, the growing elderly population is expected to be a contributing factor to the growth of the market. Furthermore, the implementation of updated wound care management protocols fosters greater unity in healthcare teams and is expected to boost market expansion. In April 2022, the Japanese Society for Burn Injuries (JSBI) released the third iteration of guidelines for inpatient burn injury treatment in Japan. The initiative aims to establish a collective approach to burn care and promote new research to substantiate evidence-based burn care and treatment practices.

Increasing Prevalence of Diabetes

One of the most common outcomes of inadequately managed diabetes mellitus is the development of diabetic foot ulcers. These ulcers typically result from inadequate foot care, peripheral vascular disease, neuropathy, and poor glycemic control. As per data from the IDF Diabetes Atlas 2021, it indicates that an estimated 11.0 million individuals aged 20-79 in Japan had diabetes. Consequently, the substantial diabetes burden in the country elevates the risk of diabetic foot ulcers, necessitating effective wound care and likely contributing to market growth during the forecast period. Moreover, the substantial prevalence and occurrence of diabetic foot ulcers are projected to make the primary wound type, necessitating wound care management in the Japanese population. As per an article published in the Journal of Foot and Ankle Research, the incidence of diabetic foot ulcers in Japan was reported at 2.9 cases per 1000 people. This heightened risk of wound complications associated with diabetes is anticipated to stimulate the demand for wound care management devices in Japan.

Product Launch and Product Approvals

Japan wound care market has witnessed several notable product approvals and launches in recent months. Among these, innovative wound dressings with advanced materials and enhanced antimicrobial properties have gained regulatory approval. These cutting-edge solutions promise improved healing outcomes and infection prevention, addressing the growing need for effective wound management in Japan’s aging population. Additionally, the introduction of smart wound care technologies, including connected devices and remote monitoring systems, has added a new dimension to patient care. These advancements signify a promising era of progress and improved patient outcomes in Japan wound care market.

In June 2021, MIMEDX Group, Inc. obtained regulatory clearance from the Japan MHLW (Ministry of Health, Labor and Welfare) for the introduction of EPIFIX in the Japanese market. EPIFIX received approval for the treatment of challenging-to-heal chronic wounds, notably diabetic foot ulcers. Its purpose is to safeguard the wound bed, promote granulation tissue formation, and provide a biocompatible human extracellular matrix. Consequently, the approval of novel products and their superior benefits are contributing to the increased adoption of wound care solutions.

Collaborations Among Leading Industry Players

Japan wound care market has witnessed several collaborations among leading industry players, fostering innovation and advancements in Japan wound care market. The partnerships aim to address the growing demand for wound care solutions, driven by an aging population and rising incidence of chronic wounds. The collaborations include pharmaceutical companies collaborating with medical device manufacturers to develop integrated wound management systems. Furthermore, wound care product manufacturers often collaborate with research institutions and healthcare providers to conduct clinical trials and studies that enhance product efficacy and safety. These partnerships are accelerating the introduction of cutting-edge wound care technologies, like advanced dressings and regenerative therapies.

In January 2023, MiMedx Group, Inc. entered an exclusive distribution partnership with Gunze Medical Limited to market EPIFIX in Japan, providing a well-established treatment choice for individuals managing chronic wounds.

Impact of COVID-19

The COVID-19 pandemic significantly influenced market growth, primarily due to disruptions in wound care management. For Instance, a study published in the Journal of General Internal Medicine in May 2021 revealed a 61% reduction in diabetic foot care services in Japan during the pandemic. Consequently, the COVID-19 outbreak substantially impacted market growth during this period. Nevertheless, telemedicine services in the region have played a vital role in enabling patients to maintain their healthcare management, including wound care. After the pandemic, areas affected by the pandemic had considerably increased access to telehealth through mobile apps, facilitating improved healthcare management.

Report Scope

“Japan Wound Care Market Assessment, Opportunities and Forecast, FY2017-FY2031”, is a comprehensive report by Markets and Data, providing in-depth analysis and qualitative and quantitative assessment of the current state of the Japan wound care market, industry dynamics and challenges. The report includes market size, segmental shares, growth trends, COVID-19, opportunities and forecast between FY2024 and FY2031. Additionally, the report profiles the leading players in the industry mentioning their respective market share, business model, competitive intelligence, etc.

Click here for full report- https://www.marketsandata.com/industry-reports/japan-wound-care-market

Latest reports-

Contact

Mr. Vivek Gupta 5741 Cleveland street, Suite 120, VA beach, VA, USA 23462 Tel: +1 (757) 343–3258 Email: info@marketsandata.com Website: https://www.marketsandata.com

[market-insider]

Market Report on Varicose Veins Treatment: Understanding Size, Share, Growth Trajectories

The global varicose veins treatment market size is expected to reach USD 2.08 billion by 2030, registering to grow at a CAGR of 6.4% from 2024 to 2030 according to a new report by Grand View Research, Inc. The increasing technological advancements coupled with the increased availability of the advanced varicose vein treatment devices and shift towards less-invasive procedures are the contributing factors for the growth of the market. 

Varicose Veins Treatment Market Report Highlights

The sclerotherapy segment was identified as the most profitable procedure owing to the benefits, such as the requirement of minimal incision and reduced scarring, related to the procedure. Moreover,the following advantages: increased penetration, cost and time efficiency, reduced risk of collateral damage to surrounding tissues, fewer post-operative complications, and painless procedure are the main contributors for the growth of this segment.

The endovenous ablation segment is expected to be the fastest growing segment due to the benefits of short treatment time and improved blood circulation after the procedure. The ClosureFast technique in the endovenous ablation treatment segmenthas gained momentum due to the minimized side effects, potential cost-saving ability, and better patient outcomes.

The endovenous chemoablation or chemical sclerosis segment was the most widely used medical procedure among the ablation procedures. Sclerotherapy, intense-pulsed-light therapy, laser ablation, radiofrequency, and ambulatory phlebectomy are the modern techniques that are usedmore oftendue to their less invasive nature.

In 2023, North America held the largest market share due to the increasing incidence rate of varicose and spider vein in the population, favourable reimbursement policies, increased healthcare awareness, government spending, and the rising aesthetic awareness in the region

The Asia Pacific is expected to register the fastest growth due to factors, such as the improving healthcare infrastructure, the increase in patient awareness level regarding the benefits of early treatment of the varicose veins, and the rising disposable income

For More Details or Sample Copy please visit link @: Varicose Veins Treatment Market Report

The huge burden of vascular diseases in Europe and North America and the increasing patient compliance and reliability, growth in healthcare expenditure, and the rapid growth in geriatric population is majorly driving the varicose vein procedure market. 

The upward trend in lifestyle disorders, such as increasing obesity, sleep disorders, blood pressure levels, hormonal changes, genetic disorders and pregnancy are the few major factors contributing to the peripheral vascular diseases. Untreated venous insufficiency, such as varicose vein and venous ulcers cause progressive syndromes including chronic veinous insufficiency. In 2015, according to FutSci, chronic veinous insufficiency is widespread and is a socially isolating condition caused in adults. It is the most common disease in the world and is estimated to affect 5% of the population in the Western countries. 

List of major companies in Varicose Veins Treatment Market

Medtronic

Lumenis Be Ltd.

AngioDynamics

Sciton

Quanta System

intros Medical Laser GmbH

Alma lasers

For Customized reports or Special Pricing please visit @: Varicose Veins Treatment Market Report

We have segmented the global varicose vein treatment market based on type, end-use and region.